Oculis Holding AG
General ticker "OCS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $762.2M (TTM average)
Oculis Holding AG follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 2.6%: low 26.00$, high 27.41$
Factors to consider:
- Total employees count: 28 as of 2022
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.98$, 26.04$]
- 2026-12-31 to 2027-12-31 estimated range: [10.92$, 22.75$]
Short-term OCS quotes
Long-term OCS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CHF0.00MM | CHF0.69MM | CHF0.00MM |
| Operating Expenses | CHF80.71MM | CHF73.89MM | CHF79.15MM |
| Operating Income | CHF-80.71MM | CHF-73.20MM | CHF-79.15MM |
| Non-Operating Income | CHF-7.98MM | CHF-12.73MM | CHF-15.54MM |
| Interest Expense | CHF1.46MM | CHF0.00MM | CHF0.80MM |
| R&D Expense | CHF29.25MM | CHF52.08MM | CHF54.52MM |
| Income(Loss) | CHF-88.69MM | CHF-85.94MM | CHF-94.69MM |
| Taxes | CHF0.00MM | CHF0.00MM | CHF0.18MM |
| Profit(Loss)* | CHF-88.80MM | CHF-85.78MM | CHF-94.51MM |
| Stockholders Equity | CHF93.73MM | CHF73.38MM | CHF196.29MM |
| Assets | CHF114.35MM | CHF120.35MM | CHF236.23MM |
| Operating Cash Flow | CHF-53.84MM | CHF-47.50MM | CHF-62.22MM |
| Capital expenditure | CHF0.05MM | CHF0.23MM | CHF0.29MM |
| Investing Cash Flow | CHF-54.21MM | CHF-17.56MM | CHF-59.38MM |
| Financing Cash Flow | CHF129.67MM | CHF54.03MM | CHF178.60MM |
| Earnings Per Share** | CHF-2.97 | CHF-2.12 | CHF-1.81 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.